SBRT 2016

Retrospective cohorts

Primary

Fract x dose

Author/year

# pts. LNmet/ total

Local control 2-years

Survival 2-years

Severe morbidity

Mixed (lung; n=20)

4 x 4Gy 10 x 5Gy

55% (1-year)

44% (1-year)

30 16 pall.

No

Chawla 2009

Holy 2011

13 (18)

NSCLC

5 x 4-8Gy

77%

50%

Grade 3 (n=2)

Mixed (lung; n=24)

Casamassima 2012

48

3 x 12Gy

90%

40%

No